Home Clinical trial underway to evaluate upper airway stimulation therapy for sleep apnea in adolescent patients with Down Syndrome

Clinical trial underway to evaluate upper airway stimulation therapy for sleep apnea in adolescent patients with Down Syndrome

An FDA-approved clinical trial is underway to evaluate the use of a hypoglossal nerve stimulator — a technology currently available to adults with severe obstructive sleep apnea (OSA) that stimulates the upper airway to facilitate breathing during sleep — in a select group of adolescent patients with Down syndrome and OSA. A case report on the first patient in the trial – whose implantation on April 8th, 2015, represented the first time the technology has been used in a pediatric patient in the United States – has now been published.

Source: www.sciencedaily.com